Smoking-cessation support for people getting lung cancer screening at MedStar Health
Official title: Providing Tobacco Treatment to Patients Undergoing Lung Cancer Screening at MedStar Health: A Randomized Trial
Funded at Georgetown University · NIH-11306567 · Data updated 2026-11-12
This project compares two ways to help people who smoke quit when they come for lung cancer screening.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgetown University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project start | April 1, 2023 |
| Project end | March 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $645,396 |
| NIH project number | 5R01CA274716-04 |
| Project ID | NIH-11306567 on NIH RePORTER |
Who could benefit from this research
✓Could help
People who currently smoke and are scheduled for lung cancer screening at one of the MedStar Health screening sites are ideal candidates.
✕Less likely to help
People who do not smoke, who are not receiving lung screening at MedStar Health, or whose health prevents use of cessation treatments may not directly benefit from this project.
What this research studies
If you smoke and are scheduled for lung cancer screening at MedStar Health, this project will offer one of two evidence-based smoking-cessation programs and randomly assign which one you receive. The trial uses real-world procedures at ten MedStar lung screening sites and adds practical strategies to improve reach and engagement, especially for racial and ethnic minorities, underinsured patients, and people not ready to quit. All eligible patients scheduled for screening will be identified through the health system and offered treatment, and outcomes like quit rates and program reach will be tracked over time. The study is designed to fit into routine care so successful approaches can be adopted by other health systems.
Why it matters
Potential benefit: If successful, this could help more people who smoke quit around the time of lung screening, reducing future lung cancer and saving lives.
How similar studies have gone: Previous studies show smoking-cessation treatments can help people quit and reduce lung cancer risk, but embedding and testing these approaches across large, diverse lung-screening programs is less common.
Where this research is happening
-
Georgetown University
Washington, United States Active
Researchers
- Principal investigator: Taylor, Kathryn L — Georgetown University
- Study coordinator: Taylor, Kathryn L
Related research
Other NIH-funded projects on the same topics.
-
Digital health strategies to expand lung cancer screening in safety-net clinics
A funded project aims to help low-resource clinics increase the use of lung cancer screening for patients who smoke or are at risk.
-
Integrated approach to lung screening and quitting for African Americans
A multi-level program aims to boost LDCT lung cancer screening uptake and help African American smokers quit, with support from a comprehensive community-focused plan.
-
Population health approach to boost lung cancer screening at community clinics
A large Utah project aims to help community clinics reach more eligible adults to get low-dose CT lung cancer screening.
-
Group-based tobacco treatment for older adults after lung cancer screening
A study tests a group-based tobacco cessation program for older adults who are getting lung cancer screening to help them quit smoking.
-
Personalized Lung Cancer Screening for Veterans
Aimed at improving who gets screened and how lung cancer is diagnosed among Veterans using personalized tools.
-
Proteogenomic framework to improve lung cancer screening with biomarkers
A biomarker-based approach aims to refine LDCT lung cancer screening so more cancers are caught early while reducing unnecessary procedures.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.